Physician profile
Emily S Minderman
NPI 1528094091
$4,165.33
in general payments reported to CMS, 2019-2025
32 companies · $458 in 2025
The $458 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $336 · 2021: $845 · 2022: $777 · 2023: $799 · 2024: $483 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,739.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,014.33 | 2019-2025 | |
| Shield Therapeutics INC | $294.29 | 2023-2025 | Accrufer |
| Pfizer INC. | $251.54 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $230.15 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $218.98 | 2023-2025 | Myfembree |
| Gynesonics, INC. | $178.55 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $175.02 | 2019-2025 | Veozah |
| Exeltis, USA INC. | $172.48 | 2019-2025 | Slynd |
| Myovant Sciences INC. | $170.30 | 2021-2022 | |
| Therapeuticsmd, INC. | $152.05 | 2019-2022 | |
| Organon LLC | $148.50 | 2021-2024 | Nexplanon |
| Medtronic, INC. | $135.35 | 2022-2024 | Truclear, V-Loc 180 |
| Daiichi Sankyo INC. | $133.55 | 2019-2021 | |
| Coopersurgical, INC. | $126.19 | 2019-2021 | |
| Agile Therapeutics, INC. | $115.92 | 2021-2023 | Twirla |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $107.14 | 2019-2025 | Thinprep 2000 Processor, Aptima, Third Wave |
| Bayer Healthcare Pharmaceuticals INC. | $100.11 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $85.70 | 2019-2021 | |
| Allergan, INC. | $61.19 | 2019-2020 | |
| Millicent US INC | $60.08 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Mylan Pharmaceuticals INC. | $42.13 | 2021 | |
| Minerva Surgical, INC | $26.15 | 2019-2023 | |
| Avion Pharmaceuticals | $24.80 | 2020 | |
| Biogen, INC. | $22.74 | 2025 | Zurzuvae |
| Ethicon US, LLC | $18.47 | 2024 | Ethicon, Harmonic |
| Urovant Sciences INC | $16.16 | 2022 | |
| Evofem Biosciences, INC. | $15.29 | 2021 | |
| Aesculap, INC. | $15.21 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.02 | 2019 | |
| Exact Sciences Corporation | $13.08 | 2024 | Cologuard Collection Kit |
| Duchesnay USA Incorporated | $13.05 | 2019 | |
| Lupin INC. | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Minderman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.